HIV infected monocytes and macrophages are involved in the pathogenesis of HIV associated neurologicaldisease (HAND). Pathologica LLC has been systematically investigating compounds that can altermacrophage activation states as potential therapeutics. This class of compounds includes polyamineanalogs (e.g. CG47) and enzymatic inhibitors of polyamine synthesis (e.g. PA-001). We have found thatpolyamine biosynthesis inhibitors (PBIs) are particularly effective at modulating and / or killing CD16 positivemacrophages. Preliminary studies at Pathologica have established that the polyamine biosynthesis inhibitorPA01 is very efficient at reducing HIV DNA loads in mononcytes in vitro and at reducing the level of SIVinfection of macrophages in the blood and tissues of rhesus macaques. However, the mechanism by whichthese beneficial outcomes were achieved remains largely unexplored. Microarray analyses of peripheralblood mononuclear cells from HIV infected individuals noted significant changes in the mRNA levels ofimmomodulatory proteins, including osteopontin and adenosine deaminase after in vitro PBI treatment.These observations are consistent with the recently described immunosuppressive role of the nativepolyamine spermine in monocytes. Accordingly, we hypothesize that PBIs kill HIV infected CD16+monocytes and macrophages via an immunomodulatory mechanism involving induction of apoptosis. Amore thorough understanding of the mechanism of action of PBIs against HIV infected macrophages will becritical to designing the most efficacious therapeutic regimens for the treatment of HAND. Accordingly, theoverall goal of Research Project 1 of this program project is to understand the mechanism by which PBIslead to reduced HIV proviral load in macrophages in vitro. Mechanistic studies will be performed onmonocytes from HIV infected individuals and SIV infected rhesus macaques. Samples provided aftertreatment of rhesus macaques (Project 2) and clinical trial participants (project 3) with PBIs will allow us toconfirm that the mechanism of action of PBIs seen in vitro also is relevant in vivo. These studies shouldprovide significant insight into the role of macrophages in the pathogenesis of HAND and identify noveltherapeutic targets for future studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19MH081835-01
Application #
7284578
Study Section
Special Emphasis Panel (ZAI1-TP-A (J2))
Project Start
2007-01-01
Project End
2011-12-31
Budget Start
2007-01-01
Budget End
2008-04-30
Support Year
1
Fiscal Year
2007
Total Cost
$292,525
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chow, Dominic C; Kagihara, Jamie M; Zhang, Guangxiang et al. (2016) Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy. HIV Clin Trials 17:114-22
Soulas, Caroline; Autissier, Patrick J; Burdo, Tricia H et al. (2015) Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques. PLoS One 10:e0119764
Meyza, Ksenia; Nikolaev, Tomasz; Kondrakiewicz, Kacper et al. (2015) Neuronal correlates of asocial behavior in a BTBR T (+) Itpr3(tf)/J mouse model of autism. Front Behav Neurosci 9:199
Jin, Xia; McGrath, Michael S; Xu, Hua (2015) Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone. J Virol 89:11176-89
Ndhlovu, Lishomwa C; Umaki, Tracie; Chew, Glen M et al. (2014) Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associa J Neurovirol 20:571-82
Chow, Dominic; Nakamoto, Beau; So, Edison et al. (2013) Rates of autonomic dysfunction in HIV patients receiving antiretroviral therapy. J Neurovirol 19:511-2
Nakamoto, Beau K; Shikuma, Cecilia M; Ogata-Arakaki, Debra et al. (2013) Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder. J Neurovirol 19:601-5
Kallianpur, Kalpana J; Shikuma, Cecilia; Kirk, Gregory R et al. (2013) Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology 80:1792-9
Shikuma, Cecilia M; Nakamoto, Beau; Shiramizu, Bruce et al. (2012) Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. Antivir Ther 17:1233-42
Kallianpur, Kalpana J; Kirk, Gregory R; Sailasuta, Napapon et al. (2012) Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex 22:2065-75

Showing the most recent 10 out of 23 publications